WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 13'3301 Infant (under 12 months) mortality rate: 62
GDP / capita (US$): 18'0341 Child (under 5 years) mortality rate: 72

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 54  53  52  52  51  46  41  43 
Births
Surviving infants
Pop. less than 5 years
Pop. less than 15 years
Female 15-49 years 14  14  14  14  13  12  11  11 

Number of reported case

(Click for retrospective incidence data for Saint Kitts and Nevis)
Diphtheria
Japanese encephalitis
Measles 80  305 
Mumps
Pertussis
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Saint Kitts and Nevis)
Vaccine year result method % card seen                                                
BCG          95  99  91  99*  95  100 
DTP1          96  97  90  99*  93  99* 
DTP3          99*  98  96  99*  99  99  100  56 
HepB_BD         
HepB3          99*  98  96  99*  98  100 
Hib3          99*  98  96  99*  97  12 
JapEnc         
MCV          95  99*  99*  99*  99  100  100 
MCV2          90  99*  99*  99*  94  99 
PCV1         
PCV3         
Pol3          99*  99  91  99*  98  99  100  76 
Rota1         
Rota_last         
Rubella1          95  99*  99*  99*  99 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Saint Kitts and Nevis)
BCG 95  99  91  93  95  99  80 
DTP1 99  99  98  99  99  99  99  79 
DTP3 97  97  95  97  98  98  99  56 
HepB3 98  98  96  97  98  99 
Hib3 98  98  96  97  97  12 
MCV 95  99  99  99  99  99  99 
PCV3
Pol3 98  98  90  94  97  98  99  76 
Rota_last

Number of districts in the country 17  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 94
From 80 to 89% 6
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 0-4 weeks; Yes
DTwP 3, 4, 5, 18 months; 4-5 years; Yes
DTwPHibHep 2, 4, 6 months; Yes
HepB 1st contact; +4 weeks; +7 months; Yes adults
IPV 2, 4, 6, 18 months; 4-5, 16 years special groups
MMR 1, 2 years; Yes
OPV 2, 4, 6, 18 months; 4-5, 16 years; Yes
Td 11, 16, 26 years; Yes & adult booster
YF Yes travelers to endemic countries

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  No  Yes  No  Yes   
What years does the MYP cover? number 2010-2011      2'010      2007-08 
Nº of districts with microplans that include activities to raise immunization coverage number 17  17  17  17  17  17  17 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR No  No  No         

System performance

Total number of districts in country number 17  17  17  17  17  17  17 
Nº districts with DTP3 coverage >=80% number 17  17  17  17  14  17  15 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  82  100  88 
Nº districts with measles (MCV1) coverage >=95% number 13  17  17  17  14     
% of districts with MCV1 coverage >=95% From 0 to 100% 76  100  100  100  82     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes    Yes  Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 100  100  100  100  100    100 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.